XXOSIXXLARXXNEWXX LIXXTED — Ras Importer Profile
Pharmaceutical Importer · #4 buyer for Ras · $1.5M import value · 30 shipments · UNITED STATES · DGFT Verified
XXOSIXXLARXXNEWXX LIXXTED is the #4 importer of Ras from India with $1.5M in import value and 30 verified shipments. XXOSIXXLARXXNEWXX LIXXTED holds a 0.5% market share in Ras imports based in UNITED STATES. The company sources from 1 verified supplier across 10 formulations shipped to 4 countries. Overall, XXOSIXXLARXXNEWXX LIXXTED imports 2 pharmaceutical products worth $1.9M across 2 therapeutic categories.
XXOSIXXLARXXNEWXX LIXXTED — Ras Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ras to XXOSIXXLARXXNEWXX LIXXTED?
Verified from 30 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| BIOCON BIOLOGICS INDIA LIMITED | $1.5M | 30 | 100.0% |
XXOSIXXLARXXNEWXX LIXXTED sources Ras from 1 verified Indian supplier based on 30 customs records. The primary supplier is BIOCON BIOLOGICS INDIA LIMITED accounting for 100.0% of imports.
How Does XXOSIXXLARXXNEWXX LIXXTED Compare to Nearest Ras Importers?
Buyers ranked immediately above and below #4 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 15 | FAWDON MANUFACTURING CENTRE ( SF ) | UNITED KINGDOM | $2.5M | 50 | $50.0K |
| 8 | DR. REDDYS LABORATORIES, INC | UNITED STATES | $1.8M | 35 | $50.0K |
| 4 | XXOSIXXLARXXNEWXX LIXXTED ★ | UNITED STATES | $1.5M | 30 | $50.0K |
| 12 | FAWDON MANUFACTURING CENTRE SF | UNITED KINGDOM | $1.3M | 26 | $50.0K |
| 13 | APOTEX - CANADA | CANADA | $950.0K | 19 | $50.0K |
XXOSIXXLARXXNEWXX LIXXTED ranks #4 among 2,323 Ras importers from India. Average shipment value of $50.0K compared to the market average of $13.6K. The closest competitors by value are FAWDON MANUFACTURING CENTRE ( SF ) and DR. REDDYS LABORATORIES, INC.
Where Does XXOSIXXLARXXNEWXX LIXXTED Import Ras To?
Destination countries from 30 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.0M | 20 | 68.6% |
| UNITED STATES OF AMERICA | $400.0K | 8 | 27.4% |
| CANADA | $50.0K | 1 | 3.4% |
| KENYA | $8.3K | 1 | 0.6% |
XXOSIXXLARXXNEWXX LIXXTED imports Ras to 4 countries. The primary destination is UNITED STATES receiving 68.6% of shipments worth $1.0M.
What Ras Formulations Does XXOSIXXLARXXNEWXX LIXXTED Import?
| Formulation | Value | Shipments |
|---|---|---|
| FULPHILA PEGFILGRASTIM-JMDB | $600.0K | 12 |
| FULPHILA (PEGFILGRASTIM-JMDB) | $300.0K | 6 |
| OGIVRI 420 TRASTUZUMAB | $150.0K | 3 |
| FULPHILA PEGFILGRASTIM- | $100.0K | 2 |
| FULPHILA (PEGFILGRASTIM- | $100.0K | 2 |
| OGIVRI TM TRASTUZUMAB | $50.0K | 1 |
| OGIVRI 150 TRASTUZUMAB | $50.0K | 1 |
| FULPHILA PEGFILGRASTIM- | $50.0K | 1 |
| OGIVRI 150 TRASTUZUMAB FOR INJECTION | $50.0K | 1 |
| TRASTUZUMAB FOR INJECTION | $8.3K | 1 |
XXOSIXXLARXXNEWXX LIXXTED imports 10 distinct Ras formulations from India. The top formulation is FULPHILA PEGFILGRASTIM-JMDB with 12 shipments worth $600.0K.
Regulatory Requirements: Importing Ras into United States
What XXOSIXXLARXXNEWXX LIXXTED and other importers must comply with to import Ras from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Ras
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Ras from India and How Much Does XXOSIXXLARXXNEWXX LIXXTED Import?
India exported $31.5M worth of Ras through 15,000 shipments from 1156 suppliers to 176 countries, serving 2,323 buyers globally. XXOSIXXLARXXNEWXX LIXXTED imports $1.5M of this total, accounting for 0.5% of India's Ras exports with 30 shipments from UNITED STATES. This is verified from 30 customs shipment records covering 10 distinct formulations.
What Is the Average Order Value for XXOSIXXLARXXNEWXX LIXXTED's Ras Imports?
XXOSIXXLARXXNEWXX LIXXTED's average Ras order value is $48.6K per consignment, based on 30 shipments totaling $1.5M. XXOSIXXLARXXNEWXX LIXXTED is based in UNITED STATES and ranks #4 among all Ras importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Ras to XXOSIXXLARXXNEWXX LIXXTED?
XXOSIXXLARXXNEWXX LIXXTED sources Ras from 1 verified Indian supplier: BIOCON BIOLOGICS INDIA LIMITED ($1.5M, 100.0%). This is based on 30 customs records.
How Does XXOSIXXLARXXNEWXX LIXXTED Compare to Other Ras Importers?
XXOSIXXLARXXNEWXX LIXXTED ranks #4 among 2,323 Ras importers from India with a 0.5% market share. The top 3 importers are MYLAN IRELAND LIMITED ($5.4M), MYLAN IRELAND LTD ($5.2M), FAWDON MAUFACTURING CENTRE (SF) ($3.5M). XXOSIXXLARXXNEWXX LIXXTED processed 30 shipments from UNITED STATES.
About XXOSIXXLARXXNEWXX LIXXTED
XXOSIXXLARXXNEWXX LIXXTED imports 2 products worth $1.9M. Beyond Ras, top products include Trastuzumab. View the complete XXOSIXXLARXXNEWXX LIXXTED profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ras — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ras shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: XXOSIXXLARXXNEWXX LIXXTED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as XXOSIXXLARXXNEWXX LIXXTED's capped import value divided by total capped export value for Ras across all Indian exporters.
- 5.Verified Records: This page is backed by 30 individual customs records matching XXOSIXXLARXXNEWXX LIXXTED importing Ras, covering 10 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 176+ countries, 2,323+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ras Import Data for XXOSIXXLARXXNEWXX LIXXTED
Access order-level details, pricing data, supplier connections, and competitive analysis for XXOSIXXLARXXNEWXX LIXXTED's Ras imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
XXOSIXXLARXXNEWXX LIXXTED
Full Company Profile →
2 products · $1.9M total trade · 2 categories
XXOSIXXLARXXNEWXX LIXXTED × Ras
Verified from customs records
Company Overview
Top Products by XXOSIXXLARXXNEWXX LIXXTED
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for XXOSIXXLARXXNEWXX LIXXTED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ras. For current order-level data, contact TransData Nexus.